Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

PCI Announces Capital Investment in Rockford Facilities

Published: Wednesday, July 10, 2013
Last Updated: Wednesday, July 10, 2013
Bookmark and Share
Leading pharmaceutical packaging firm investing in support of business growth.

Packaging Coordinators Inc (PCI) has announced further investment in its Rockford facilities in support of business growth and expansion.

The company acquired AndersonBrecon Inc. in May of this year and is adding additional equipment capacity and facilities infrastructure through capital investment, as well as hiring in support of business growth.

The company provides packaging services for pharmaceutical and healthcare products, working with leading Pharmaceutical and Biotech companies to bring lifesaving medicines to patients.

PCI operates 9 facilities in the greater Rockford, Illinois area totaling over 1 million square feet and employing over 1,300 highly trained associates.

PCI is owned by an entity formed by affiliates of lead investor Frazier Healthcare, a leading provider of growth equity and venture capital to high growth and emerging healthcare service and Biotech companies.

Continued Growth and Expansion
PCI’s Rockford location is experiencing its fourth straight year of significant growth. The company is experiencing substantial growth in 2013, which is anticipated to continue in 2014 and beyond.

In support of this growth, PCI has hired approximately 160 associates since January of 2012. Positions added include hourly, skilled labor, as well as management.

In addition to hiring, the company is looking to support new business by expanding its machine capacity, warehousing, and facilities infrastructure. PCI has added multiple blister packaging and bottling lines to meet increased demand in Ethical (prescription) and Over-the-Counter pharmaceutical markets and plans additional investment in this area.

The company is also investing in support of growth markets including commercial Biotech medicines and Clinical (Investigational) medicines.

Capital investments include expansion of on-site refrigerated Cold Chain storage capacity at 2 – 8° Celsius, -20° Celsius, and -80° Celsius.

A History Of Investment
The company opened a stand-alone potent compound packaging facility in 2010 and a new Clinical (Investigational) medicines packaging facility in 2011.

PCI’s largest Rockford facility, located at the Greater Rockford Industrial Park, was most recently expanded in 2008 and comprises over 720,000 square feet.

PCI’s North American and European sites feature state-of-the-art packaging facilities and cutting edge technologies, supporting very recognizable brands in the global healthcare market.

The company packages medicines destined for patients spanning over 100 countries across the globe. PCI’s headquarters in Philadelphia, PA employs approximately 475 associates.

A facility in Woodstock, IL employs approximately 125 additional associates. PCI’s domestic locations are complemented by four packaging sites in Wales, which currently employ approximately 300 associates, mainly in support of pharmaceutical products for the European region.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

PCI Announces Definitive Agreement to Acquire Penn Pharma
PCI’s expands service offering with acquisition of Penn Pharma.
Thursday, July 31, 2014
Peter Belden Named General Manager of PCI Rockford Facilities
Belden returns to PCI North America to manage Rockford, IL operations.
Monday, September 02, 2013
Scientific News
Study Finds Brain Chemicals that Keep Wakefulness in Check
Researchers to develop new drugs that promote better sleep, or control hyperactivity in people with mania.
Sorting Through Cellular Statistics
Aaron Dinner, professor in chemistry, and his graduate student Herman Gudjonson are trying to read the manual of life, DNA, as part of the Dinner group’s research into bioinformatics—the application of statistics to biological research.
Playing 'Tag' with Pollution lets Scientists See Who's It
Using a climate model that can tag sources of soot from different global regions and can track where it lands on the Tibetan Plateau, researchers have determined which areas around the plateau contribute the most soot — and where.
Women’s Immune System Genes Operate Differently from Men’s
A new technology reveals that immune system genes switch on and off differently in women and men, and the source of that variation is not primarily in the DNA.
Long Telomeres Associated with Increased Lung Cancer Risk
Genetic predisposition for long telomeres predicts increased lung adenocarcinoma risk.
First Artificial Ribosome Designed
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell.
High-Resolution 3D Images Reveal the Muscle Mitochondrial Power Grid
NIH mouse study overturns scientific ideas on energy distribution in muscle.
Expanding the Brain
A team of researchers has identified more than 40 new “imprinted” genes, in which either the maternal or paternal copy of a gene is expressed while the other is silenced.
Identifying a Key Growth Factor in Cell Proliferation
Researchers discover that aspartate is a limiter of cell proliferation.
Study Uncovers Target for Preventing Huntington’s Disease
Scientists from Cardiff University believe that a treatment to prevent or delay the symptoms of Huntington’s disease could now be much closer, following a major breakthrough.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!